Cargando…
Can Neuron Specific Enolase Be a Diagnostic Biomarker for Neuronal Injury in COVID-19?
Neuron specific enolase (NSE) is a biomarker for neuronal injury. However, increased levels in cerebrospinal fluid (CSF) and serum is associated with the clinical outcome in patients with head injury, ischemic stroke, intracerebral hemorrhage, cardiac arrest, anoxic encephalopathy, encephalitis, bra...
Autores principales: | Ganti, Latha, Serrano, Enrique, Toklu, Hale Z |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673275/ https://www.ncbi.nlm.nih.gov/pubmed/33214960 http://dx.doi.org/10.7759/cureus.11033 |
Ejemplares similares
-
Serum Visinin-Like Protein 1 Is a Better Biomarker Than Neuron-Specific Enolase for Seizure-Induced Neuronal Injury: A Prospective and Observational Study
por: Tan, Zheren, et al.
Publicado: (2020) -
Cerebrospinal fluid findings and hypernatremia in COVID-19 patients with altered mental status
por: Toklu, Hale, et al.
Publicado: (2020) -
The ratio of serum neuron-specific enolase level to admission glasgow coma scale score is associated with diffuse axonal injury in patients with moderate to severe traumatic brain injury
por: Chen, Weiliang, et al.
Publicado: (2022) -
Serum neuron-specific enolase: A promising biomarker of silicosis
por: Huang, Hong-Bo, et al.
Publicado: (2021) -
Neuron-specific enolase serum levels in COVID-19 are related to the severity of lung injury
por: Cione, Erika, et al.
Publicado: (2021)